Navigating to Success
If you need guidance in financing, developing and commercializing your medical device or diagnostics innovation, you've come to the right place.
medical technology investorsatonpartners2019-01-01T21:02:53+00:00
Experience and success go hand in hand.
ATON Partners offer management consulting services anchored in real life knowledge of the industry.
Patrick Sullivan and Daniel Levangie have led highly successful medical devices and diagnostics companies from the development of early concept stage technology, through to commercialization and eventual highly profitable exits. With more than 20 years of operating experience, ATON Partners has a deep knowledge of building companies with innovative and medical practice-changing technologies and products.
Tales of success
Sullivan and Levangie most recently led the investment and development of the Bloodhound Fully Integrated Hematology System - a highly disruptive technology focused on revolutionizing an entrenched standard of care in a 1 billion annual test market in hematology. Blood hound was acquired by Roche Diagostics for $220MM in July 2013.
ATON Partners will leverage their decades long experience with inventors and entrepreneurs to develop, test, and commercialize similar game-changing medical device and diagnostics technologies.
Sullivan and Levangie headed the emergence of Cytyc Corporation as the leading company delivering innovative solutions for women's health problems. This included the introduction of ThinPrep Pap Test System, the NovaSure Endometrial Ablation System, the MammoSite Targeted Radiation System, and Fetal Fibroectin Testing for pre-term delivery. Each proved to be innovative, disruptive, cost effective, standard-of-care-changing technologies. And was acquired by Hologic, Inc. for $6.2B USD in 2007.
Put our knowledge and experience to work for you.
Daniel LevangieManaging Partner
Dan has a vast knowledge of the medical industry. For years, he was Chief Commercial Officer and President of the Cytyc Surgical Products Division.
Daniel Levangie is an experienced executive with senior operating experience in the field of medical devices and in vitro diagnostics. Mr. Levangie is currently the Chairman and Chief Executive Officer of Cerevasc, LLC and co-founder and Managing Partner of ATON Partners, LLC, a Boston based private investment and management consulting firm. Most recently, Mr. Levangie was Chief Executive Officer of Dune Medical Devices and co-founder and Managing Partner of Constitution Medical Investors, Inc. (CMI) a Boston-based private investment and product development firm acquired by Roche Diagnostics Corporation in July 2013. Prior to that Mr. Levangie was Chief Executive Officer of Keystone Dental, Inc., a Warburg Pincus portfolio company involved in dental reconstruction technologies and Chairman of the Board of ev3.
Beginning in 1992 Mr. Levangie held a variety of executive management positions with Cytyc Corporation until the acquisition of Cytyc Corporation by Hologic, Inc. in October of 2007. Those positions included Executive Vice President and Chief Operating Officer, Chief Executive Officer and President of Cytyc Health Corporation, Executive Vice President and Chief Commercial Officer and President, Cytyc Surgical Products Division.
Prior to joining Cytyc Corporation in 1992, Mr. Levangie held a number of sales, marketing and management positions with Abbott Laboratories, North Chicago, IL.
Mr. Levangie resides in Boston, MA with his wife Joan, and is a member of the Board of Directors of Exact Sciences, Inc. and Dune Medical Devices, LTD. He previously served as Lead Director of Insulet Corporation and Director of Liposcience, Inc. Mr. Levangie, a graduate of the College of Pharmacy of Northeastern University in Boston, is a member of the Advisory Board of the Barnett Institute of Northeastern University and is a trustee of Excel Charter School.
Patrick SullivanManaging Partner
Former President of Cytyc Corporation, Patrick has grown businesses and launched global medical products.
Patrick Sullivan is an experienced executive with an outstanding track record in managing early stage medical device and diagnostics ventures through all phases of growth. He is currently Managing Partner of ATON Partners, LLC and is President & Chief Executive Officer of Insulet Corporation (PODD). Prior to these roles Mr. Sullivan served as Chairman & CEO of Constitutional Medical Investors from 2008 until its sale to Roche Diagnostics Hematology in July 2013. From 1991 through 2007 Mr. Sullivan served in a variety of senior executive positions with Cytyc Corporation including Chairman, President and Chief Executive Officer until the acquisition of Cytyc Corporation by Hologic Corporation in October of 2007. Prior to joining Cytyc, Mr. Sullivan was employed in several senior marketing positions by Abbott Laboratories, a diversified healthcare company, and was a consultant with McKinsey & Company, an international management-consulting firm. Mr. Sullivan holds a Bachelor of Science degree, with Distinction, from the United States Naval Academy and a Master of Business Administration degree, with Distinction, from Harvard Business School. Mr. Sullivan is a Director of CereVasc, Perkin-Elmer Corporation and Theragenics Corporation.
We will guide your company through the turbulent waters of commercialization, iternational markets, reimbursement, regulatory, investor relations and finance.